Koninklijke Philips N.V.
PHIA
Classifica tra le azioni
#940
Koninklijke Philips N.V. operates as a leading global healthcare technology... Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within the Diagnosis & Treatment segment, Philips offers advanced diagnostic imaging technologies, including magnetic resonance (MRI), computed tomography (CT), X-ray systems, and innovative detector-based spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. The company also provides integrated interventional systems and comprehensive echography (ultrasound) solutions, crucial for diagnosis, treatment planning, and guidance in areas like cardiology, general imaging, obstetrics/gynecology, and point-of-care settings. This segment is further supported by proprietary software platforms designed to facilitate diagnostics and interventions, as well as enterprise diagnostic informatics products and related services. The Connected Care division focuses on solutions for critical patient management, emergency response, and sleep and respiratory conditions. Additionally, it delivers electronic medical record (EMR) and broader care management platforms. For Personal Health, Philips provides a range of consumer products, encompassing oral hygiene solutions such as electric toothbrushes, brush heads, and interdental cleaning and teeth whitening systems. This segment also includes infant feeding and digital parenting solutions, along with male grooming and beauty devices. Philips actively pursues strategic collaborations to enhance its offerings, notably partnering with Ibex Medical Analytics Ltd. to jointly promote digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company also maintains a strategic partnership agreement with NICO.LAB. Established in 1891 and headquartered in Amsterdam, the Netherlands, the company adopted its current name, Koninklijke Philips N.V., in May 2013, having previously operated as Koninklijke Philips Electronics N.V.
Prezzo delle azioni
$26.28
Capitalizzazione di mercato
$25.69B
Variazione (1 giorno)
-4.18%
Variazione (1 anno)
-7.76%
Paese
NL
Scambia Koninklijke Philips N.V. (PHIA)
Categoria
Healthcare
Cronologia dei frazionamenti azionari per Koninklijke Philips N.V. (PHIA)
L’azione Koninklijke Philips N.V. (simbolo: PHIA) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Oct 21, 2026.
Una quota di PHIA acquistata prima di Oct 21, 2026 equivale oggi a 0 quote di PHIA.
L’ultimo frazionamento è avvenuto il Oct 21, 2026.
Una quota di PHIA acquistata prima di Oct 21, 2026 equivale oggi a 0 quote di PHIA.
Elenco dei frazionamenti azionari
| Anno | Frazionamento | Moltiplicatore | Moltiplicatore cumulativo |
|---|---|---|---|
| Non abbastanza dati per le date fornite. | |||
Frazionamenti azionari di aziende simili o concorrenti
| Azienda | Numero di frazionamenti azionari | Moltiplicatore cumulativo | Il paese |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 2 | x4 |
US
|
|
| 0 | - |
DE
|
